DUBLIN–(BUSINESS WIRE)–The “Digital Marketing Trends in Severe Asthma” report has been added to ResearchAndMarkets.com’s offering.
Sanofi/Regeneron’s Dupixent.com achieved the highest traffic across branded severe asthma patient sites in the US from July 2021 to June 2022, with about 7,800,000 visits, followed by Novartis’ Xolair.com, and GSK’s Nucala.com.
The highest proportion of traffic to these sites originated from direct sources, followed by organic searches….
Source link
